Siemens Sets a New Standard for Breast Ultrasound

SiemensSiemens Healthcare recently introduced the Acuson S2000 Automated Breast Volume Scanner (ABVS), the first multi-use ultrasound breast system that automatically acquires volume images of the breast. Thanks to the user-independent, standardized image acquisition, the system is ideally suited for early detection and diagnosis of breast cancer with ultrasound - especially for women with dense breast tissue.

According to the New England Journal of Medicine(1), dense breast tissue increases the risk of breast cancer for a woman up to five-fold. While mammogr phy remains the method of choice in breast cancer screening, a study published by the RSNA (Radiological Society of North America) in 2002(2) showed that the detection rate for non-palpable, invasive breast cancer increased by 42 percent when mammography was followed by an ultrasound examination.

"I am convinced that automatic ultrasound volume imaging with the Acuson S2000 ABVS can make a significant contribution in diagnostic confidence for women with dense breast tissue or inconclusive mammography findings," said Klaus Hambüchen, CEO, Ultrasound at Siemens Healthcare. Examinations performed with the Acuson S2000 ABVS technique generally take less than 15 minutes. "Time well spent if you consider the extended diagnostic capabilities of ultrasound in dense breasts."

Coronal anatomical view
The system quickly and comfortably acquires and surveys full-field sonographic volume images that provide a more comprehensive overview of the breast. Included is the intuitive, anatomical coronal plane of the breast (from the nipple to the breast wall), which is not available with conventional ultrasound imaging. This view provides a more understandable representation of the global anatomy and architecture of the breast.

The system's automatic image acquisition significantly improves the workflow of a breast ultrasound examination. While hand held examinations usually take up to 30 minutes, with the Acuson S2000 ABVS, the exam can be performed in less than 15 minutes. Semi-automated reporting and comprehensive BI-RADS® ultrasound reporting capabilities further enhance the clinical workflow. This Breast Imaging Reporting and Data System (BI-RADS) is a classification of the American College of Radiology (ACR) for reporting mammography screenings.

To further optimize high-volume patient care, the system also supports innovative breast imaging applications, such as Fatty Tissue and eSie Touch elasticity imaging. All of these applications help increase diagnostic confidence, while at the same time reducing examination and waiting time for the patient. The new system is an all-round system for ultrasound breast care, from early detection, to diagnosis to aftercare.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the largest suppliers of healthcare technology in the world. The company is a medical solution provider with core competences and innovative strengths in diagnostic and therapeutic technologies as well as knowledge processing, including information technology and system integration. With its acquisitions in laboratory diagnostics, Siemens Healthcare is the first integrated healthcare company that combines imaging and lab diagnostics, therapy solutions and medical information technology and also supplements these with consultation and services. Siemens Healthcare offers solutions for the entire supply chain under one roof - from prevention and early detection to diagnosis and on to treatment and aftercare. In addition, Siemens Healthcare is the global market leader for innovative hearing instruments. The company employs some 49,000 employees worldwide and is present in more than 130 countries. During fiscal 2008 (ending on September 30), Siemens Healthcare achieved sales of 11.17 billion euros and incoming orders totaling 11.78 billion euros. The Sector profit from operations amounted to 1.23 billion euros. For more information, go to: http://www.siemens.com/healthcare.

1. N Engl J Med 356;3. Boyd N.F. et Al., Mammographic Density and the Risk and Detection of Breast Cancer
2. Radiology 2002;225:165-175. Kolb T.M. et Al., Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...